Castle Biosciences (CSTL) PT Lowered to $35 at Baird
Tweet
Share
E-mailGet Alerts CSTL Hot Sheet
Price: $29.95 +1.11%
Rating Summary:
10 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
10 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Baird analyst Catherine Schulte lowered the price target on Castle Biosciences (NASDAQ: CSTL) to $35.00 (from $38.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Castle Biosciences gains dual listing on Nasdaq Texas
- Samsonite International SA (1910:HK) (SMSEY) PT Lowered to HK$19.60 at Macquarie
- Enovix Corporation (ENVX) PT Lowered to $5 at BofA Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
